Fairuza Ahmed

Fairuza Ahmed

Auto-generated profile, based on publicly available information

Fairuza Ahmed

Department of Pharmacy, BRAC University, Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Pharmacotherapy and Pharmascience Discovery
Verified
Journal Article
Closed access
MRMd Abu Rayhan
Md Abu Rayhan
NVNusrat Jahan Vabna
Nusrat Jahan Vabna
FAFairuza Ahmed
Fairuza Ahmed
AHArif Hossin
Arif Hossin
KNKashfia Nawrin
Kashfia Nawrin
MBMohammad Mustakim Billah
Mohammad Mustakim Billah
Background: A search for novel anxiolytic agents has been the prime target for neuroscientists as the currently available treatment methods have certain limitations like physiological dependence, delayed efficacy and side effects. However, naturally occurring agents are raising hopes. The present study was aimed to evaluate the effects of Ziziphus jujube honey over stress related anxiety behavior in Swiss Albino mice. Methods: Following Jujube honey administration (at 2g/kg, 4g/kg and 6g/kg; body weight), the experimental mice were employed in open field and hole-cross test apparatus to evaluate neurologic properties and the anxiolytic activities were investigated using elevated plus maze test (EPM). Mice behavior were observed through parameters of square crossing, rearing, grooming, hole crossing, entry and duration in open arm at different time intervals. Results: At higher doses (6g/kg), Jujube honey was found to possess mild sedative-anxiolytic activity whereas in lower doses (2g/kg & 4g/kg), a non-sedative; anxiolytic potential was observed. Diazepam was effective enough to reduce the locomotor activity and anxiety in all the experiments specially at late phases. Conclusion: The results demonstrated that the anti-anxiety potential of Jujube honey is dose dependent and could be utilized in broad spectrum in inducing sedation and reducing anxiety in mice. Therefore, jujube honey potentiates scopes for further research as a CNS agent.

1 April 2021 in Pharmacotherapy and Pharmascience Discovery
Verified
Journal Article
Closed access
KNKashfia Nawrin
Kashfia Nawrin
MBMohammad Mustakim Billah
Mohammad Mustakim Billah
FAFairuza Ahmed
Fairuza Ahmed
AHArif Hossin
Arif Hossin
RTRazwanur Rahman Tushar
Razwanur Rahman Tushar
MIMohammad Nurul Islam
Mohammad Nurul Islam
Background: In different parts of the world, citrus fruit peels are considered potential sources for natural anti-inflammatory agents. The present study was designed to evaluate the anti-inflammatory potential of Citrus. sinensis fruit peel in search for a natural alternative medicine. Methods: In vitro inflammation was modeled through egg albumin denaturation, human erythrocyte membrane destabilization- in hypotonic and thermal conditions; treated with the aqueous peel extract at various concentrations - 31.25, 62.5, 125, 250 and 500 μg/ml and compared with the same concentrations of the reference acetyl salicylic acid (ASA). Half maximal inhibitory concentration (IC50) was determined from the dose-response curve. In addition, phytochemical and physicochemical properties were also assessed. Results: In all experiments, IC50 of the test sample was achieved at higher concentrations (>200 μg/ml). However, in hypotonic and hyperthermic conditions, IC50 was attained at much higher concentrations (>250 μg/ml). ASA showed greater responses in inhibition in comparison to that of the sample. The qualitative phytochemical analysis exhibited that the aqueous extract contained protective components like tannin, phenol, flavonoid, reducing sugar, protein, carbohydrate and steroid. Conclusion: The demonstration of anti-protein denaturation and erythrocyte membrane stabilization indicated a significant potential of the aqueous fruit peel extract as natural anti-inflammatory agent which generated the context for further in-depth investigation.

1 April 2021 in Pharmacotherapy and Pharmascience Discovery
Verified
Journal Article
Closed access
MBMohammad Mustakim Billah
Mohammad Mustakim Billah
KNKashfia Nawrin
Kashfia Nawrin
MRMd Abu Rayhan
Md Abu Rayhan
FAFairuza Ahmed
Fairuza Ahmed
AHArif Hossin
Arif Hossin
MIMohammad Nurul Islam
Mohammad Nurul Islam
Background: Honey, derived from different botanical sources, have already been reported for the scientific basis of their antibacterial efficacy, however, varied to a great extent when sourced from different geographical locations. Thus, this study was aimed to highlight the antibacterial potential of honey derived from Bangladesh, Germany and Australia as well as to assess their potency to enhance the efficacy of standard antibiotics against resistant bacteria. Methods: In vitro susceptibility of four resistant gram-positive bacterial strains to honey samples and their combinations with standard antibiotics (penicillin and amoxiclav) were investigated. The evaluation of antibacterial activity was performed by disc diffusion method as well as microdilution method using two-fold dilutions of honey samples ranging from 12.5µg/ml to 0.78µg/ml. Zone of inhibition, percentage inhibition, MIC and MBC were observed in this regard. Results: The results revealed that tested honey samples exhibited noticeable antibacterial activity against the bacterial strains. Maximum inhibition zone was observed by Bangladeshi honey (20.4mm) against M. luteus and highest inhibition percentage was demonstrated by German honey against B. subtilis (82%). Combinations with amoxiclav showed nearly two-fold increase in efficacy by all honeys, when treated against all species. Conclusion: The findings from this study suggested that, in addition to having inhibitory effects, all honey also enhanced the pharmacological action of penicillin and amoxiclav and could generate a potential research focus to establish a supplement for these antibiotics.

1 April 2021 in Pharmacotherapy and Pharmascience Discovery
Verified
Journal Article
Closed access
SHSamira Hassan
Samira Hassan
FAFairuza Ahmed
Fairuza Ahmed
RTRazwanur Rahman Tushar
Razwanur Rahman Tushar
LJLaila Jahan
Laila Jahan
AHAbul Hossen
Abul Hossen
Background: The aim of this study was to evaluate the pharmaceutical equivalence of different brands of Domperidone tablets marketed in Bangladesh and study their release kinetics model. Methods: Five different brands of Domperidone tablets were purchased from different pharmacies from Dhaka, Bangladesh. The quality control parameters of domperidone tablets were determined by identification, weight variation, disintegration, assay and dissolution tests and the results were compared with USP and BP pharmacopoeia standards. Difference (f1) and similarity (f2) factors were calculated to assess in vitro bioequivalence requirements. Finally, drug release kinetics were studied through model-dependent calculative methods. Results: The results of assay, weight variation and disintegration tests indicated that all samples complied with USP specification limits. The active pharmaceutical ingredients quantitative assay showed that all the brands of domperidone tablets were between the 95% and 105% limit of the label claim met the range of f1 (0-15) and f2 (>50). All brands best fitted in Korsmeyer-Peppas model indicating diffusion mediated release and also shown low AIC in Hixson-Crowell model assuming the release governed by velocity of dissolution. Conclusion: This study revealed that all the domperidone brands met the quality specification of weight variation, disintegration, assay and dissolution. The study also indicated similarity in the dissolution profile of the brands of domperidone tablets with the reference product. Hence, selected generic brands could be substituted with the reference product in clinical practice.

1 April 2021 in Pharmacotherapy and Pharmascience Discovery
Verified
Journal Article
Closed access
MBMohammad Mustakim Billah
Mohammad Mustakim Billah
AHArif Hossin
Arif Hossin
KNKashfia Nawrin
Kashfia Nawrin
FAFairuza Ahmed
Fairuza Ahmed
Microtubule associated protein, Tau characterizes a number of neurodegenerative disorders grouped as Tauopathies including Alzheimer’s disease (AD) and tau associated frontotemporal lobar degeneration (FTLD-tau). The molecular pathogenesis of these tauopathies involves post-translational modifications of Tau such as phosphorylation and truncation. However, there are other PTMs such as acetylation, methylation, ubiquitination which contribute to the pathogenesis as well. In recent years, a remarkable number of investigations have been efforted on Tau in relation to AD or FLTD-tau which has provided a body of new insights on the possible mechanisms on tau pathology. These involve but not limited to the contexts of tau phosphorylation, Tau-RNA Interaction, MAPT translation suppression, new non-aggregative tau identification, Aβ mediated exosomal tau seed, Clusterin enhanced tau aggregation, co-factor-free tau seed, co-occurrence of tau accumulation and microglial activation, tau acetylation mediated CMA inhibition, Viral ligand-receptor interactions mediated seed transmission, autophagy etc. Early detection is considered as preliminary step in disease management. Recent studies demonstrated positron emission tomography (PET) as an efficient scanner of abnormal tau which has revealed new possibilities of predicting memory impairment, level of toxic tau, detecting previously undetected diffuse pathology and identification of tau generation and deposition. Reports also suggest new advancement on understanding of physiological management of tau pathologies by autophagy mediated tau degradation, inhibition of amyloid formation and tau accumulation. This review summarizes the recent evidences on the nature and action of tau protein with regard to AD and other tauopathies to accumulate new insights into possible mechanisms underlying, detection and diagnosis, biological management and therapeutic strategies.

1 April 2021 in Pharmacotherapy and Pharmascience Discovery
Verified
Journal Article
Closed access
AOAbeer Hasan Olive
Abeer Hasan Olive
FAFairuza Ahmed
Fairuza Ahmed
MBMohammad Mustakim Billah
Mohammad Mustakim Billah
Background: Antibacterial efficacy of neem oil has been well documented in literatures for their traditional and scientific basis of use. Though plenty of research have already been conducted, very few have been focused to revive weak antibiotic standards against resistant bacteria with its combination. Thus, the present study was designed to rejuvenate penicillin with combined use of neem oil. Methods: Four gram-positive and two gram-negative resistant bacteria were selected for the study. Antibacterial efficacy was analyzed by disc diffusion method and microdilution method where zones of inhibition were measured and percentage of inhibition were calculated. Results: Neem oil demonstrated firm antibacterial efficacy against all bacteria in its individual application. Moreover, its combination with penicillin boosted the efficacy with synergism against S. aureus, M. luteus, E. coli and P. aeruginosa, however, on the contrary, decreased the efficacy against S. epidermis and B, megaterium. Conclusion: The study concludes that neem oil possesses higher synergistic potential which can facilitate the efficacy of penicillin against resistant bacteria. However, further investigation is required to understand the underlying mechanism of inhibition. Significance Statement: The study obtained three new findings; first, the broad-spectrum synergistic effect of neem oil observed when combined with penicillin; provided a clue for revival of penicillin; second, the synergism against gram-negative bacteria was greater than that against gram-positive bacteria; third, unorthodoxly the combination also found to reduce the antibacterial efficacy than that of neem oil’s solo application against two gram-positive bacteria.